Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
10/17/1996 | CA2216858A1 Phospholipase c homolog |
10/17/1996 | CA2216655A1 New borneol esters, process for their production, and their pharmaceutical use |
10/17/1996 | CA2216104A1 Compositions and methods for treating pain |
10/17/1996 | CA2215840A1 Dermatological preparation and method for treating actinic keratoses |
10/17/1996 | CA2215389A1 Pharmaceutical compositions comprising synthetic peptide copolymer for prevention of gvhd |
10/17/1996 | CA2192597A1 Use of a cationic amphipathic compound as a transfection agent, vaccine additive or drug |
10/16/1996 | EP0737750A2 Expression of exogenous polynucleotide sequences in a vertebrate |
10/16/1996 | EP0737685A1 Pyridine derivatives, process for their preparation and pharmaceutical compositions containing them |
10/16/1996 | EP0737683A1 N-2-(Phthalimido)ethyl trans-piperidine-2,5-dicarboxylates as intermediates in the preparation of perhydro-1H-pyrido[1,2-a]pyrazines |
10/16/1996 | EP0737680A1 (Phenylalkylaminoalkyloxyl)-hetero-aryl compounds, processes and intermediates for their preparation and medicaments containing these compounds |
10/16/1996 | EP0737678A1 4-Indolylpiperazinyl derivatives |
10/16/1996 | EP0737677A1 4-Indolylpiperazinyl derivates |
10/16/1996 | EP0737676A1 Prostaglandin derivative, salt thereof, and use thereof |
10/16/1996 | EP0737670A1 Tricyclic amides, processes for their preparation, and pharmaceutical compositions containing them |
10/16/1996 | EP0737478A1 Use of alkaline earth metal salts for the treatment of pruritis, eye or eyelid pain or disesthesies |
10/16/1996 | EP0737477A1 Percutaneously absorbable preparation |
10/16/1996 | EP0737476A2 A pharmaceutical preparation containing a 3-(2H)-furanone derivative for prevention and/or treatment of cataracts |
10/16/1996 | EP0737475A2 Treatment and control of ocular development with a muscarinic antagonist |
10/16/1996 | EP0737474A2 Benzoyl peroxide compositions |
10/16/1996 | EP0737248A1 Gene expression control |
10/16/1996 | EP0737211A1 Cationic biopolymers |
10/16/1996 | EP0737203A1 Steroidal glycosides |
10/16/1996 | EP0737202A1 Hypocholesterolemic agents |
10/16/1996 | EP0737200A1 Biologically active silicon compounds and their therapeutic and cosmetic applications |
10/16/1996 | EP0737199A1 Method for preparing concentrated biologically active silicon compounds |
10/16/1996 | EP0737197A1 Amino alkanoic esters of rapamycin |
10/16/1996 | EP0737196A1 Diaryl 5,6-fused heterocyclic acids as leukotriene antagonists |
10/16/1996 | EP0737195A1 New ginkgolide derivatives and a process for preparing them |
10/16/1996 | EP0737194A1 Diazabicyclic neurokinin antagonists |
10/16/1996 | EP0737193A1 Pyrazolopyridine adenosine antagonists |
10/16/1996 | EP0737192A1 Substituted morpholine derivatives and their use as therapeutic agents |
10/16/1996 | EP0737190A1 [4-(1,2-epoxycyclohexanyl) but-3-en-1-ynyl] aromatic and heteroaromatic acids and derivatives having retinoid-like biological activity |
10/16/1996 | EP0737189A1 Heterocyclic compounds for the treatment of cns and cardiovascular disorders |
10/16/1996 | EP0737187A1 Benzoxazine derivatives, methods for obtaining same and their use as drugs |
10/16/1996 | EP0737186A1 Process for the preparation of leukotriene antagonists |
10/16/1996 | EP0737185A1 7- carboxyalkyl or alkenyl]-6- alkyl or alkenyl] 3-oxo-2,4-dioxobicyclo- 3.2.1] octane and derivatives thereof |
10/16/1996 | EP0737184A1 Cyclopentane(ene) heptenoic or heptanoic acids and derivatives thereof useful as therapeutic agents |
10/16/1996 | EP0737176A1 Process for isomerizing linear olefins to isoolefins |
10/16/1996 | EP0737072A1 A method of preventing or reducing the risk of infection by bacterial pathogens utilizing simple and conjugated dextrans |
10/16/1996 | EP0737070A1 Vitamin d 3? analogues and pathway to mediate disorders |
10/16/1996 | EP0737069A1 Deuterised active agents in transdermal application |
10/16/1996 | EP0737068A1 2,3-diaryl-1-benzopyrans for treating dermatitis |
10/16/1996 | EP0737067A1 Method of treatment of hormone-unresponsive metastatic prostate cancer |
10/16/1996 | EP0737065A1 Process for preparing solid pharmaceutical dosage forms |
10/16/1996 | EP0737062A1 Water-in-oil lotion containing a corticosteroid |
10/16/1996 | EP0670837B1 Method of preparing beta-carbolines |
10/16/1996 | EP0648254B1 Luminescent article with high phosphor to binder ratio and manufacture thereof |
10/16/1996 | EP0639176B1 Benzenedimethanol suitable for micronisation |
10/16/1996 | EP0589957B1 Use of atipamezole for the treatment of male sexual impotence |
10/16/1996 | EP0581955B1 Use of benzimidazole derivatives as protective light filters |
10/16/1996 | EP0571546B1 Chroman and thiochromans with phenylethynyl substituents at the 7-position having retinoid-like biological activity |
10/16/1996 | EP0540673B1 Acetylene derivatives having lipoxygenase inhibitory activity |
10/16/1996 | EP0526529B1 An improved process for the preparation of substituted indolone derivatives |
10/16/1996 | EP0524989B1 Controlled release drug formulation |
10/16/1996 | EP0482175B1 Fault tolerant computer system |
10/16/1996 | CN1133596A 'Delta' 16 unsaturated C17 heterocyclic steroids useful as steroid C17-20 lyase inhibitors |
10/16/1996 | CN1133593A Piperazine compounds used in therapy |
10/16/1996 | CN1133561A Stabilized prostaglandin E 1 |
10/16/1996 | CN1133560A A stable pharmaceutical composition of terfenadine and isuprofen |
10/16/1996 | CN1133559A photosensibilizers |
10/16/1996 | CN1133298A Gaseous polymerization method |
10/16/1996 | CN1133296A 11 beta-aromatic group-4-estraene and acid additive salt application in medicine |
10/16/1996 | CN1133294A Closed-large ring lactone and closed-azalactone group new compounds and preparation process thereof |
10/16/1996 | CN1133293A Platinum matches and medicine for malignant tumor containing said platinum matches |
10/16/1996 | CN1133292A Light-filtering agent, sun-screening agent cosmetic compositions containing said light-filtering agent and usage thereof |
10/16/1996 | CN1133291A Erythromycin derivant and preparation method and usage of medicine thereof |
10/16/1996 | CN1133289A Substituted 4-phenyl thiazole derivant, preparation and medicine compositions thereof |
10/16/1996 | CN1133288A Compound with 1-(aryl Chain olefine)-4-(aryl methyl) piperazine structure, preparation process thereof and medicine thereof |
10/16/1996 | CN1133287A Inhibitor for squalene synthetic enzyme |
10/16/1996 | CN1133189A Oral liquid for body building up |
10/16/1996 | CN1133177A External use medicine for seborrheic alopecia |
10/16/1996 | CN1133173A Preparation of diuretic by using neuropsychic tension antagonist |
10/16/1996 | CN1133172A Powdered preparation for treating wounds and lesions |
10/16/1996 | CN1033033C 19, 11 beta-bridged steroids with progestone anti-activity preparation method |
10/16/1996 | CN1033032C Prepn. of 19-substituted progesterone derivatives |
10/16/1996 | CN1033031C Modified prepn. of gangliosides and functional derivatives thereof |
10/16/1996 | CN1033030C Preparation of macrocyclic bifunctional chelants, complexes thereof and their antibody conjugates |
10/16/1996 | CN1033029C Prepn. of indenoindole compound |
10/16/1996 | CN1033028C Process for preparing new derivatives of 2,2-dimethyl cyclopropane carboxylic acid |
10/15/1996 | US5565613 2-arylpropionic acid preparations and process for their production |
10/15/1996 | US5565589 17-formyl-5,6-trans-vitamin D compounds |
10/15/1996 | US5565586 Oxidative process for the preparation of allyl quinone derivatives |
10/15/1996 | US5565584 1-alkyl-, 1-alkenyl-, and 1-alkylnlaryl-2-amino-1,3-propanediols and related compounds |
10/15/1996 | US5565582 Gastrointestinal disorders |
10/15/1996 | US5565580 Treatment of central nervous system disorders |
10/15/1996 | US5565579 Neuroprotective agent |
10/15/1996 | US5565571 Substituted aryl- and heteroaryl-phenyloxazolidinones |
10/15/1996 | US5565565 One step akylation and concurrently generating the akylation catalyst |
10/15/1996 | US5565562 Triaza macrocycles |
10/15/1996 | US5565561 Natural substance cyclamenol and chemical derivatives |
10/15/1996 | US5565560 Treating autoimmune diseases, preventing transplant rejection |
10/15/1996 | US5565559 Culturing an fr-900506; protecting; salt formation; oxidation; reduction; deprotecting |
10/15/1996 | US5565495 Periodically administering selegiline (or salt) to middle-aged dog |
10/15/1996 | US5565494 Benzenesulfonylurea derivatives |
10/15/1996 | US5565493 Collagen metabolism ameliorant and its use in the stimulation of hair growth |
10/15/1996 | US5565492 Prostaglandin combinations in glaucoma therapy |
10/15/1996 | US5565491 Use of phosphotyrosine phospatase inhibitors for controlling cellular proliferation |
10/15/1996 | US5565488 Oxalylamino-benzofuran- and benzothienyl-derivatives |
10/15/1996 | US5565487 Method of treating wrinkles using galactonic acid or galactonolactone |
10/15/1996 | US5565486 Administering culture product of the fungus acremonium strictum as an anticonvulsant, anxiolytic agent, muscle relaxant, hypnotic or memory enhancer |